医脉通重续与M3的关联交易协议
医脉通（02192）发布补充公告，内容涉及与M3的持续关联交易。根据2024年11月11日的公告，医脉通将重续精确营销及企业解决方案服务框架协议，并对相关定价政策及年度上限的内部控制程序进行了进一步说明。为确保交易依照2024年重续协议的定价条款进行，医脉通将实施一系列内部控制措施。
具体而言，M3需通过书面请求向医脉通发起服务要求，医脉通的调研部门将基于所需服务及规格提供报价，并与独立第三方的现行费率保持一致。所有报价需经过营销管理部审阅，并在确认后方可执行。此外，财务管理中心将每月监测交易金额，若累计交易金额达到年度上限的80%，财务总监将评估是否需要调整年度上限，确保合规性。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10